National glycopeptide-resistant enterococcal bacteraemia surveillance Working Group report to the Department of Health - August 2004.
Brown
D F J
DF
Clinical Microbiology and Public Health Laboratory, Health Protection Agency, Addenbrooke's Hospital, Cambridge CB2 2QW, UK. dfjb2@cam.ac.uk
Brown
N M
NM
Cookson
B D
BD
Duckworth
G
G
Farrington
M
M
French
G L
GL
King
L
L
Lewis
D
D
Livermore
D M
DM
Macrae
B
B
Scott
G M
GM
Williams
D
D
Woodford
N
N
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D016983:Enterococcus / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D006020:Glycopeptides / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007755:Laboratories, Hospital; D011159:Population Surveillance / Q000379:methods*; D012307:Risk Factors; D011795:Surveys and Questionnaires; D006113:United Kingdom / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D006020:Glycopeptides